What did @drlorashahine actually say?
The short version: a thin endometrial lining despite estrogen supplementation is a real clinical problem, and the doctor said workup should start with figuring out why, potentially including hysteroscopy. She also mentioned trying different estrogen protocols and delivery systems as a next step.
This is a response video, so she is answering a specific user question rather than delivering a lecture. The framing is practical and patient-facing. She name-drops saline sonograms and "histerous helpingagrams" (almost certainly hysterosalpingograms, or HSGs) as screening tools done before fertility treatment. She then describes hysteroscopy as a procedure that can catch things those screening tools miss. Her closing note is essentially: "keep trying different protocols." That is a short answer to a genuinely complicated question, and it shows.
Does the science back this up?
Yes, mostly. The recommendation to investigate the cause before escalating treatment is textbook-appropriate, and hysteroscopy really does add diagnostic value beyond ultrasound and HSG alone. The claim that different estrogen delivery systems matter is also supported by data, though less robustly than she implies.
A 2019 systematic review by Mahajan et al. in the Journal of Human Reproductive Sciences confirmed that a thin endometrium (typically defined as under 7 mm) is associated with significantly reduced implantation rates in frozen embryo transfer cycles. Causes include intrauterine adhesions (Asherman syndrome), prior uterine surgery, chronic endometritis, and poor blood flow. Tan et al. (2022, Frontiers in Endocrinology) showed that transdermal estrogen sometimes produces better endometrial response than oral estradiol in women who fail to respond, which supports her point about delivery systems. Hysteroscopy's diagnostic superiority over HSG for intrauterine pathology is well-established (Demirol and Gurgan, 2004, Fertility and Sterility).
What did they get wrong (or right)?
She got the broad strokes right. The problem is what she left out, which matters a lot for a patient who is already on estrogen and not responding.
She does not mention chronic endometritis, which is one of the more underdiagnosed causes of a thin or poorly receptive endometrium. It requires an endometrial biopsy and antibiotic treatment, not just more estrogen. A 2015 study by Cicinelli et al. in the American Journal of Reproductive Immunology found chronic endometritis in a meaningful proportion of women with repeated implantation failure, many of whom had no symptoms.
She also skips blood flow entirely. Suboptimal uterine artery perfusion is a real contributor, and sildenafil or low-dose aspirin protocols are used in some clinics, though the evidence is mixed (Sher and Fisch, 2002, Human Reproduction). That is worth at least a mention.
The mispronunciation of hysterosalpingogram as "histerous helpingagram" is sloppy for a credentialed fertility doctor speaking on a medical platform, but it does not change the accuracy of the underlying advice. Give credit where it is due: recommending hysteroscopy as a next step for persistent thin lining is the right call.
What should you actually know?
If you are on estrogen supplements and your lining is still not thickening, "just keep trying" is not a complete strategy. You need a diagnosis first.
The differential for estrogen-resistant thin endometrium includes: intrauterine adhesions, chronic endometritis, poor uterine vascularity, prior endometrial damage from curettage or infection, and in rarer cases, estrogen receptor dysfunction. Each of these has a different treatment path. Hysteroscopy, as the doctor recommends, is genuinely the gold-standard tool for ruling out structural causes. An endometrial biopsy during that procedure can also rule out chronic endometritis, which antibiotics can treat.
On the estrogen delivery question: oral estradiol, transdermal patches, vaginal tablets, and injections do produce different systemic and local effects. If one is not working, switching is a reasonable clinical move. But there is no single protocol proven superior for all patients (Glujovsky et al., 2020, Cochrane Database of Systematic Reviews). This is a decision that belongs in a conversation with your reproductive endocrinologist, not a TikTok comment.
Bottom line
This video is broadly accurate but thin on clinical depth, which is a fair trade-off for a 60-second social media reply. The advice to investigate the cause and consider hysteroscopy is sound. The advice to try different protocols is reasonable. What is missing is a fuller picture of what those causes actually are and why some of them need targeted treatment, not just more estrogen.